PA
HDSN

PharVision Advisers’s Hudson Technologies HDSN Stock Holding History

PharVision Advisers’s Portfolio HDSN Stock Details HDSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,799
Closed -$316K – 820
2025
Q3 		$316K Buy
+31,799
New +$298K 0.18% 200
2025
Q1 		– Sell
-33,162
Closed -$185K – 379
2024
Q4 		$185K Buy
+33,162
New +$219K 0.16% 323

Other funds holding HDSN

HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's HDSN Position: Q4 2025 in Review

PharVision Advisers sold out of Hudson Technologies (HDSN) in Q4 2025, closing a stake of 31,799 shares — an estimated $316K sold.

PharVision Advisers first reported a position in HDSN in Q4 2024 and held it in 2 quarters. The position peaked at $316K in Q3 2025. 168 funds tracked by Wall St. Rank hold HDSN as of Q4 2025.

  • PharVision Advisers reported no remaining Hudson Technologies position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 31,799 Hudson Technologies shares in Q4 2025, an estimated $316K.
  • PharVision Advisers first reported a position in Hudson Technologies in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Hudson Technologies position peaked at $316K in Q3 2025.
  • 168 funds tracked by Wall St. Rank held Hudson Technologies as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.